Looks like MSB are not involving a partner.
No matter what is promoted on here, even if Mesoblast received a quick sr-GVHD approval in 2024 we don't have the funds to complete this CLBP trial on our own without $ from somewhere like a partnership deal ? It doesn't necessarily have to be a CLBP partnership deal; funds would also be incoming through a CHF partnership deal but again on our own reliant totally on Remestemcel-L revenues from a quick FDA approval - not going to happen IMO
..... oh and of course don't even get me started on if we receive another CRL
GLTAH
Looks like MSB are not involving a partner. No matter what is...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.005(0.47%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.10 | $1.06 | $3.371M | 3.135M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 45345 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 3875 | 2 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |